Dyne Therapeutics, Inc. DYN Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Dyne Therapeutics, Inc. (DYN) reported operating lease right-of-use assets in other assets of $19.65M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Dyne Therapeutics, Inc.'s operating lease right-of-use assets in other assets decreased by 17.7% year-over-year, from $23.88M to $19.65M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s operating lease right-of-use assets in other assets has grown at a 96.9% compound annual growth rate (CAGR), from $700K to $20.74M.